Emergency Use Authorizations for the Decontamination of N95 Respirators The U.S. Food and Drug Administration has issued emergency use authorizations for select sterilization systems that will allow N95 or N95-equivalent respirators to be decontaminated. The sterilization systems will help address the shortage of these vital masks used by healthcare workers to protect themselves from exposure to the novel coronavirus. This May 4 webinar features an expert from 3M who addresses the 3M perspective on the decontamination of N95 respirators and shares important caveats about doing so, as well as representatives from STERIS, Battelle, Advanced Sterilization Products (ASP), and Sterilucent, each of whom have systems covered by EUAs. Following the expert presentations, is a Q&A session.

AAMI’s annual business meeting will be held virtually on Friday, June 12 at 1:00 p.m. ET. On the agenda for the meeting is the official election of nominated members for the AAMI Board of Directors. Once elected, their terms will begin immediately after the meeting.

The Food and Drug Administration (FDA) published a final guidance document outlining how medical device manufacturers (MDMs) can submit a request for nonbinding feedback on issues documented during agency inspections and how the agency will evaluate and respond to such requests. By providing timely feedback, the FDA hopes MDMs will be equipped to quickly and effectively resolve safety and quality issues with their devices.